Chordate Medical’s CEO, Anders Weilandt, and CSO, Jan Hermansson, will participate and exhibit at the European Headache Congress from December 6 to 9 alongside Chordate’s Italian distributor, Vedise Hospital S.p.A. Chordate will present Ozilia and share the case study from the migraine study PM007.
“EHC is one of the largest gatherings for physicians and professionals in the headache field in general, and the migraine sector in particular. We anticipate a significant number of Italian delegates at the congress, and Vedise can address inquiries about Ozilia,” says Anders Weilandt.
The theme of the 2023 European Headache Congress is “Headache: Expanding the horizon,” and over the four days of the congress, the latest developments and innovations in the headache field will be highlighted. In addition to Italy, delegates from other important European markets for Chordate.
“This is another opportunity for us to raise awareness about Ozilia. We have participated in several congresses in recent months, and the interest in Ozilia has been substantial,” says Anders Weilandt.